XML 97 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Based Compensation
12 Months Ended
Dec. 31, 2014
Stock-Based Compensation [Abstract]  
STOCK BASED COMPENSATION

NOTE 11 - STOCK BASED COMPENSATION

The Company’s shareholders approved the Norwood Financial Corp 2006 Stock Option Plan at the Annual Meeting on April 26, 2006. An aggregate of 275,000 shares of authorized but unissued Common Stock of the Company were reserved for future issuance under the Plan. This includes up to 44,000 shares for awards to outside directors. Under this plan, the Company granted 12,500 options to employees in 2014, 28,600 options, which included 4,000 options granted to outside directors in 2013, and 30,250 options, which included 4,950 options granted to outside directors in 2012. 

 

At the Annual Meeting held on April 22, 2014, the Company’s shareholders approved the Norwood Financial Corp 2014 Equity Incentive Plan. An aggregate of 250,000 shares of authorized but unissued Common Stock of the Company were reserved for future issuance under the Plan. This includes up to 40,000 shares for awards to outside directors. The Plan also authorized the Company to award restricted stock to officers and outside directors, limited to 42,000 shares of restricted stock awards for officers and 8,000 shares of restricted stock awards for outside directors. Under this plan, the Company granted 9,300 shares, which included 2,800 shares to outside directors, in 2014.  All shares granted in 2014 were for restricted stock.  The restricted shares vest over a five-year period.  The product of the number of shares granted and the grant date market price of the Company’s common stock determine the fair value of restricted stock under the company’s restricted stock plan.  Management recognizes compensation expense for the fair value of restricted stock on a straight-line basis over the requisite service period for the entire award.

 

Total unrecognized compensation cost related to stock options was $66,000 as of December 31, 2014, $157,000 as of December 31, 2013, and $154,000 as of December 31, 2012.  Salaries and employee benefits expense includes $154,000,  $162,000 and $130,000 of compensation costs related to options for the years ended December 31, 2014, 2013 and 2012, respectively. There was no cost attributable to restricted stock recognized in the year ended December 31, 2014.  The expected future compensation expense relating to the 9,300 shares of non-vested restricted stock outstanding as of December 31, 2014 is $271,000.    Net income was reduced by $146,000,  $154,000 and $123,000 for the years ended December 31, 2014, 2013 and 2012, respectively.

 

A summary of the Company’s stock option activity and related information for the years ended December 31 follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2013

 

2012

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

Average

 

 

 

Average

 

Average

 

 

 

Average

 

Aggregate

 

 

 

Exercise

 

Intrinsic

 

 

 

Exercise

 

Intrinsic

 

 

 

Exercise

 

Intrinsic

 

Options

 

Price

 

Value

 

Options

 

Price

 

Value

 

Options

 

Price

 

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, beginning of year

219,540 

 

$

26.64 

 

 

 

 

225,670 

 

$

26.27 

 

 

 

 

229,836 

 

$

25.85 

 

$

 

Granted

12,500 

 

 

29.08 

 

 

 

 

28,600 

 

 

27.07 

 

 

 

 

30,250 

 

 

27.05 

 

 

 

Exercised

(25,577)

 

 

27.05 

 

 

 

 

(24,127)

 

 

23.83 

 

 

 

 

(20,435)

 

 

22.19 

 

 

 

Forfeited

 -

 

 

 -

 

 

 

 

(10,603)

 

 

28.92 

 

 

 

 

(13,981)

 

 

26.88 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, end of year

206,463 

 

$

26.74 

 

$

477,640 

 

219,540 

 

$

26.64 

 

$

146,970 

 

225,670 

 

$

26.27 

 

$

256,499 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, end of year

193,963 

 

$

26.59 

 

$

477,640 

 

190,940 

 

$

26.58 

 

$

146,900 

 

196,489 

 

$

26.15 

 

$

256,499 

 

 

 

Exercise prices for options outstanding as of December 31, 2014 ranged from $24.44 to $29.08 per share. The weighted average remaining contractual life is 5.7 years.

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing with the following weighted average assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

2014

 

2013

 

2012

Dividend yield

 

3.57%

 

 

3.49%

 

 

3.27%

Expected life

 

10 years

 

 

10 years

 

 

10 years

Expected volatility

 

24.97%

 

 

25.91%

 

 

25.37%

Risk-free interest rate

 

2.17%

 

 

3.01%

 

 

1.76%

Weighted average fair value of options granted

$

5.30

 

$

5.72

 

$

5.61

 

 

The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts.

 

Proceeds from stock option exercises totaled $691,000 in 2014. Shares issued in connection with stock option exercises are issued from available treasury shares. If no treasury shares are available, new shares are issued from available authorized shares. During 2014, all the shares issued in connection with stock option exercises, 25,577  shares in total, were issued from available treasury shares.

 

All share and per share data have been adjusted to give retroactive effect to the 10% stock dividend declared in 2013.

 

As of December 31, 2014, outstanding stock options consist of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

Average

 

Options

 

Exercise

 

Remaining

 

Options

 

Exercise

 

Outstanding

 

Price

 

Life, Years

 

Exercisable

 

Price

 

19,063 

 

 

27.62 

 

1.3 

 

19,063 

 

 

27.62 

 

17,600 

 

 

28.64 

 

2.0 

 

17,600 

 

 

28.64 

 

17,600 

 

 

28.41 

 

3.0 

 

17,600 

 

 

28.41 

 

18,700 

 

 

25.00 

 

4.0 

 

18,700 

 

 

25.00 

 

1,100 

 

 

26.27 

 

4.3 

 

1,100 

 

 

26.27 

 

17,600 

 

 

25.99 

 

5.0 

 

17,600 

 

 

25.99 

 

1,100 

 

 

24.44 

 

5.2 

 

1,100 

 

 

24.44 

 

22,550 

 

 

25.25 

 

6.0 

 

22,550 

 

 

25.25 

 

24,750 

 

 

24.97 

 

7.0 

 

24,750 

 

 

24.97 

 

25,300 

 

 

27.05 

 

8.0 

 

25,300 

 

 

27.05 

 

1,100 

 

 

27.55 

 

8.0 

 

1,100 

 

 

27.55 

 

2,000 

 

 

28.95 

 

8.7 

 

2,000 

 

 

28.95 

 

25,500 

 

 

26.90 

 

9.0 

 

25,500 

 

 

26.90 

 

12,500 

 

 

29.08 

 

10.0 

 

 -

 

 

 -

Total

206,463 

 

 

 

 

 

 

193,963 

 

 

 

 

 

A summary of the Company’s restricted stock activity and related information for the year ended December 31, 2014 is as follows:

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

Number of

 

Grant Date

 

 

Restricted Stock

 

Fair Value

 

 

 

 

 

Outstanding, beginning of year

 

-

 

-     

Granted

 

9,300 

 

$
29.08 

Vested

 

 -

 

 -

Forfeited

 

 -

 

 -

Non-vested at December 31, 2014

 

9,300 

 

$
29.08